戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ing observable cold defense mechanisms (e.g. shivering).
2 g, arteriovenous shunt vasoconstriction, and shivering.
3 cing the thresholds for vasoconstriction and shivering.
4 erimental cold exposure designed to minimize shivering.
5 e comfortable in the cold, and reported less shivering.
6  and clinical protocols on how to best treat shivering.
7 nverse relationship between BAT activity and shivering.
8 are arteriovenous shunt vasoconstriction and shivering.
9  can also produce heat metabolically without shivering.
10      Nine patients experienced mild episodic shivering.
11 widely expressed uncoupling protein UCP2, or shivering.
12 abituation of cutaneous vasoconstriction and shivering.
13                                              Shivering (152 [37%] vs 59 [15%]; RR 2.54, 95% CI 1.95-3
14                                              Shivering (229 [47%] vs 82 [17%]; RR 2.80, 95% CI 2.25-3
15                                              Shivering after anesthesia or in the critical care setti
16  Brown adipose tissue (BAT) functions in non-shivering and diet-induced thermogenesis via its capacit
17 iac arrest requires deep sedation to prevent shivering and discomfort.
18    Surface CW provides beneficial control of shivering and improves the metabolic profile during TTM.
19 ratory distress syndrome, but cooling causes shivering and increases metabolism.
20 ections resulted in short-lived increases in shivering and longer decreases in locomotor activity, as
21             Skeletal muscle is a key site of shivering and non-shivering thermogenesis, but the impor
22             Skeletal muscle is a key site of shivering and non-shivering thermogenesis, but the impor
23 e of thermoregulation was caused by impaired shivering and nonshivering thermogenesis, whereas thermo
24  sham controls and iBAT-ablated mice stopped shivering and resumed routine physical activity, indicat
25  ingestion at 52 degrees C rapidly decreased shivering and sensations of cold compared to 37 degrees
26 id ingestion at 22 and 7 degrees C increased shivering and sensations of coolness to similar levels,
27 al fat deposition and fur growth, short-term shivering and sweating or panting, and movement between
28 n, fluid ingestion at 52 degrees C decreased shivering and the sensation of coolness, whereas fluid i
29              With LRG ingestion, compared to shivering and thermal sensations with ingestion at 37 de
30 t study, we characterize the modification of shivering and whole-body thermal sensation during cold s
31 delayed drug metabolism, prolonged recovery, shivering, and thermal discomfort.
32                    Both vasoconstriction and shivering are associated with autonomic and hemodynamic
33 s scored on a scale of 0-3 using the Bedside Shivering Assessment Scale (BSAS).
34 s in puberty, either dystonic/dyskinetic or "shivering" attacks, triggered by stretching, motor initi
35 he time of IDC, 72% of patients had signs of shivering (BSAS >0).
36  the development of wild boars is not due to shivering but explained by the observed increase in SERC
37 irmed that the industrial sections; cutting, shivering/crusting, and stitching were the principal con
38  were decreases in body movements, including shivering, during NREM sleep; body temperature and heart
39 scuss complications of hypothermia including shivering, electrolyte abnormalities, hemodynamic change
40 , and brown adipose tissue temperatures; and shivering EMGs in anesthetized rats following central an
41 ) and clonidine (100 mug/kg, i.v.) inhibited shivering EMGs, BAT SNA, and BAT thermogenesis, effects
42  symptoms of nausea, persistent diarrhea and shivering fever under consecutive treatments with ICPIs,
43 y control, and prevents vasoconstriction and shivering in blocked areas.
44 -blocking agents may be used to manage overt shivering in therapeutic hypothermia.
45 fe, total heat production was improved while shivering intensity decreased, indicating an increasing
46                                     Although shivering is one alternative mechanism of thermogenesis
47                                              Shivering occurred more frequently in the Arctic Sun gro
48 n in a dose-dependent manner without causing shivering or altering physiological parameters.
49  use (p = 0.03), baseline moderate to severe shivering (p = 0.04), and lower serum magnesium levels (
50                                          The shivering response appeared to be delayed and much reduc
51  on four occasions, to induce a steady-state shivering response, at which point two aliquots of 1.5 m
52 mine whether visceral thermoreceptors modify shivering responses to cold stress.
53 nalysis using linear comparisons calculating shivering risk-reduction ratios.
54  misoprostol group more commonly experienced shivering (RR 1.91, 95% CI 1.65 to 2.21, p<0.001) and fe
55                                              Shivering severity during each phase was scored on a sca
56  thermogenesis is a key player in muscle non-shivering thermogenesis (NST) and can compensate for los
57                                Canonical non-shivering thermogenesis (NST) in brown and beige fat rel
58 ge amount of circulating glucose to fuel non-shivering thermogenesis and defend against hypothermia.
59 ults indicate a potent inhibition of BAT and shivering thermogenesis by alpha2-AR activation in the r
60 bition of rat brown adipose tissue (BAT) and shivering thermogenesis by alpha2-AR agonists.
61 ulature during adrenergic stimulation of non-shivering thermogenesis by norepinephrine, a vasoconstri
62                      Especially in the cold, shivering thermogenesis enables foraging as well as prop
63 asculature changes during stimulation of non-shivering thermogenesis have never been directly detecte
64  in obesity, but the effect of impairing non-shivering thermogenesis in BAT on lipid storage in WAT r
65 brown adipose tissue (BAT) to facilitate non-shivering thermogenesis in mammals, but what regulates m
66 protein-1 (UCP1), which mediate adaptive non-shivering thermogenesis in mammals.
67 nes on brown adipose tissue suggest that non-shivering thermogenesis is an arena for intragenomic con
68                            Activation of non-shivering thermogenesis is considered a promising approa
69                                    While non-shivering thermogenesis is mediated primarily by uncoupl
70                                          Non-shivering thermogenesis is required for survival of rode
71                              In rodents, non-shivering thermogenesis is responsible for a large part
72                                          Non-shivering thermogenesis of brown adipose tissue (BAT) is
73 rown adipose tissue (BAT) is the primary non-shivering thermogenesis organ in mammals, which plays es
74 to an inhibition of brown adipose tissue and shivering thermogenesis that is mediated by neurons in t
75   Several studies have shown that during non-shivering thermogenesis the increase in BAT oxygen deman
76 t tissue specialized in heat production (non-shivering thermogenesis) and used by mammals to defend c
77 nd acute cold tolerance (partly a measure of shivering thermogenesis) in s/s mice were modestly but s
78 the first day of cold, a time of intense non-shivering thermogenesis, AMPK activity remained at basal
79 al muscle is a key site of shivering and non-shivering thermogenesis, but the importance of mitochond
80 al muscle is a key site of shivering and non-shivering thermogenesis, but the importance of mitochond
81  dissipates energy through mitochondrial non-shivering thermogenesis, thus representing a powerful ag
82 wn adipose tissue (BAT), a key organ for non-shivering thermogenesis, to variations in nutritional st
83 both species, which may serve to augment non-shivering thermogenesis.
84 g efficiency, which may serve to augment non-shivering thermogenesis.
85 s, re-routing fatty acids to BAT to fuel non-shivering thermogenesis.
86 apacity of brown adipose tissue and thus non-shivering thermogenesis.
87 ssue, and not in the acute activation of non-shivering thermogenesis.
88 ue (BAT) is a type of fat specialized in non-shivering thermogenesis.
89 issue may increase energy expenditure by non-shivering thermogenesis.
90 tentially contributor to skeletal muscle non-shivering thermogenesis.
91 trols mammalian core body temperature by non-shivering thermogenesis.
92 s the mitochondrion, generating heat for non-shivering thermogenesis.
93 istochemical techniques, for evidence of non-shivering thermogenesis.
94 osure by increasing brown adipose tissue and shivering thermogenesis.
95 d the study of possible UCP1-independent non-shivering thermogenic mechanisms, whose existence has be
96 rd pathway mediates not only sympathetic and shivering thermogenic responses but also metabolic and c
97                                          The shivering threshold is usually a full 1 degrees C below
98 travenous meperidine were used to reduce the shivering threshold.
99 , triggering of the ventilator and degree of shivering) to assess the degree of neuromuscular blockad
100                                              Shivering was common in the misoprostol group, and nause
101 AT thermogenesis and survive by compensatory shivering with consequent acute weight loss.

 
Page Top